Pancreatic Cancer Research

ResearcherLMU KlinikumActive in the last 2 years

Haochen Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8356-1828; OpenAlex author ID A5064848623. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 1 paper

Papers 3

  1. Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer. Co-author DOI 10.21037/tcr-24-505↗
  2. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma. Last author DOI 10.1155/2022/9141117↗
  3. Prognostic value of regulator T cells in patients with pancreatic cancer: a systematic review and meta-analysis. Last author DOI 10.26355/eurrev_202204_28622↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kaifeng Su · 2 shared papers, 2022 · strength 0.52
  2. Dongyao Pu · 1 shared paper, 2024 · strength 0.23
  3. Yingkun Xu · 1 shared paper, 2024 · strength 0.23
  4. Shengchun Liu · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.